NASDAQ · STOCK
Bristol Myers Squibb
$65.30
52W $42.52 – $65.66
58/100
$133.37B
14.4
0.23
Is BMY Bullish or Bearish?
Mixed.
Innellis AI committee rates Bristol Myers Squibb (BMY) Watch with a composite score of 58/100
, based on 6 analysts with 50% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +2.08 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -17.92 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 15.9% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- RSI at 78 is in overbought territory — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
- Bollinger bandwidth of 15.9% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
58/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 24%
of 93 Healthcare peers
Growth Analyst
bullish
82
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
57
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 78 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 15.9% signals elevated volatility
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
70
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.40 across 99 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score strengthened from 54.5 to 57.9.
- Committee agreement increased modestly from 43% to 50%.
- New bearish signals: 5 appeared.
- Bullish support removed: 4 signal(s) disappeared.
- New bullish signals: 3 appeared.
- Bearish pressure eased: 6 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
- Analyst(s) abstained: Value Analyst.
Analyst-level changes:
- Growth Analyst: score 72->82 (+10); +1 bullish signal(s).
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- News Analyst: score 62->70 (+9); +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Risk Analyst: score 30->35 (+5); +1 bearish signal(s).
- Technical Analyst: +2 bearish signal(s).
- Value Analyst abstained (was neutral at 50).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
79.6
Overbought
MACD Histogram
0.480
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Lh Ll
Support
$63.22
Resistance
$66.22
Bollinger %B
0.97
Inside Bands
Price vs Moving Averages
EMA 9
$62.98
Above
EMA 21
$60.98
Above
EMA 50
$59.18
Above
EMA 200
$56.22
Above
Fundamental Analysis
Valuation
77
Growth
87
Profitability
1
Financial Health
45
Cash Flow
37
Valuation
P/E Ratio
14.4×
P/B Ratio
5.98×
PEG Ratio
0.17
Dividend Yield
0.04%
52W High
$65.66
52W Low
$42.52
Quality & Growth
ROE
38.2%
ROA
7.8%
Gross Margin
70.2%
Operating Margin
28.3%
Revenue Growth YoY
—
Debt / Equity
1.93
AI Fundamental Assessment
P/E ratio of 14.4 (inexpensive relative to a 15-40x range); Price-to-book of 6.0x; PEG ratio of 0.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.4%; Return on assets of 0.1%; Net margin of 0.2%; Gross margin of 0.7%; Current ratio of 1.53 (healthy short-term liquidity); Debt-to-equity of 1.93; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (6.02); Most recent quarter beat estimates by 27.2%; 5 consecutive earnings beats; EPS growth accelerating (+25.4% -> +29.1% QoQ); Average YoY EPS growth of 39.7%; Analyst estimates rising over recent quarters
Get the Full BMY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →